In this interactive recording of a live CCO webinar, Jonathan M. Meyer, MD, discusses pharmacotherapy of antipsychotic-induced movement disorders and reviews the 2021 American Psychiatric Association recommendations on managing antipsychotic-induced parkinsonism, acute dystonia, akathisia, and tardive dyskinesia (TD); the rationale for avoiding routine or prolonged anticholinergic use to manage antipsychotic-related parkinsonism or dystonia; why anticholinergics worsen TD; and the latest recommendations on effective TD management.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.